X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

A new era in genomics

By Andrew Powaleny  |    April 26, 2017
Personalized medicine has taken on a new meaning with the mapping of the human genome.   Read More

Australia is making it harder to protect inventions. That’s bad for American businesses and jobs.

By Jay Taylor  |    April 25, 2017
Bringing a single new medicine to market requires substantial resources over many years. To ensure continued investment in the development of tomorrow’s breakthrough treatments and cures,...   Read More

Medicare Monday: Stakeholders raise concern with MedPAC’s proposed changes to drug purchasing program

By Nicole Longo  |    April 24, 2017
A couple weeks ago, we looked at what a broad group of stakeholders have said about the recommended changes to Part B that the Medicare Payment Advisory Commission (MedPAC) voted in support of....   Read More

The risks of counterfeit imported medicines

By Allyson Funk  |    April 20, 2017
A recent Wall Street Journal article laid out the serious concerns posed by potent, counterfeit prescription opioids pouring into the United States from China, Mexico and Canada. The Drug...   Read More

Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs

By Robert Zirkelbach  |    April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...   Read More

Trading fair means upholding the law: A focus on patents

By Jay Taylor  |    April 18, 2017
Patents are the linchpin of innovation. In the United States and other countries around the world, they provide temporary protection for new inventions. A fair, stable and predictable patent...   Read More

Mental health in the New Era of Medicine

By Bill Chin, M.D.  |    April 18, 2017
Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental...   Read More

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

By Lucy Vereshchagina  |    April 17, 2017
In an exciting step forward to support research and development of innovative new medicines and devices for pediatric patients, the Critical Path Institute (C-Path) announced the launch of a new...   Read More

Driving innovation through collaboration

By Emma Van Hook  |    April 17, 2017
A new report from Deloitte examines the changing landscape of biopharmaceutical research, as stakeholders across the R&D ecosystem are increasingly coming together to tackle sciences’ most vexing...   Read More

Medicare Monday: Another example of the competitive market at work in Part D

By Nicole Longo  |    April 17, 2017
Hepatitis C is a devastating viral disease that can result in life-threatening and costly complications. Five years ago, the only available treatment for the disease often resulted in debilitating...   Read More

Enforcing unmet trade obligations protects U.S. innovation

By Jay Taylor  |    April 11, 2017
The United States leads the world in medical innovation, helping patients across the globe access the latest life-saving treatments and cures. Trade agreements with other nations serve as the...   Read More

Medicare Monday: What they are saying about MedPAC’s Part B recommendations

By Nicole Longo  |    April 10, 2017
Last week, the Medicare Payment Advisory Commission (MedPAC) voted on a number of recommendations affecting Medicare Part B. These proposed changes could negatively impact patients’ access to Part...   Read More

This is not a special effect: New video shows the destruction of a rogue cell

By Robert Zirkelbach  |    April 10, 2017
In the latest video of our Cells series, part of the GOBOLDLY™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million...   Read More

12 years of the Partnership of Prescription Assistance

By Hannah Mooney  |    April 5, 2017
Today, the Partnership for Prescription Assistance (PPA) is celebrating 12 years of helping connect patients who struggle with affordable access to the medicines they need. Because PPA serves as a...   Read More

RA medicines often demonstrate far greater benefits to patients than initially understood

By Lauren Neves  |    April 5, 2017
In the last decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients’ treatment options and significantly improved outcomes,...   Read More

NAFTA tribunal fails to rule on Canada’s patent utility doctrine

By Mark Grayson  |    April 4, 2017
While Canada may have prevailed in the recent North American Free Trade Agreement (NAFTA) tribunal case against Eli Lilly, the promise utility doctrine continues to harm their economy. And,...   Read More

ICYMI: Report highlights overall decrease in cancer death rates

By Andrew Powaleny  |    April 3, 2017
In case you missed it, cancer death rates are continuing to decrease for men, women and children in the United States thanks in part to biopharmaceutical innovation, according to the Annual Report...   Read More

Medicare Monday: A guide to MedPAC’s Part B vote this week

By Allyson Funk  |    April 3, 2017
The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises Congress on issues related to the Medicare program, including payment, access to and quality...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates